India Corporate Governance MCA ROC Filings — October 24, 2026

Q2 FY27 revenue from operations up 31.1% YoY to ₹9,576.93 lakh and 10.7% QoQ, with H1 FY27 revenue of ₹18,225.15 lakh up 31.7% YoY

Q2 FY27 net profit down 54.7% YoY to ₹326.02 lakh and 65.9% QoQ from ₹954.99 lakh, indicating sharp margin erosion despite volume growth

H1 FY27 profit declined 4.8% YoY to ₹1,281.01 lakh even as H1 revenue rose 31.7%, showing operating leverage is currently negative

Other expenses up 20.4% YoY to ₹1,651.51 lakh and employee costs up 11.8% YoY to ₹1,603.11 lakh, outpacing revenue growth of 31.1% only on a relative basis but compressing margins in absolute terms

Other income collapsed to ₹9.44 lakh from ₹40.74 lakh YoY (down roughly 77%), removing a cushion that previously supported reported earnings

Sequential revenue growth of 10.7% QoQ indicates demand momentum entering H2 FY27

Board appointed Mrs. Mamta Nirmal Shah as Non-Executive Non-Independent Director, subject to postal ballot approval; a routine governance step with no evident insider-control concern

Net profit fell 54.7% YoY and 65.9% QoQ while revenue grew, indicating cost base is scaling faster than the top line

Other expenses up 20.4% YoY to ₹1,651.51 lakh, the fastest-growing cost line, requires explanation from management

Employee benefit expenses up 11.8% YoY to ₹1,603.11 lakh, adding fixed cost pressure if volumes soften

Other income dropped to ₹9.44 lakh from ₹40.74 lakh, meaning core operating profitability is now the sole earnings driver

H1 profit declined 4.8% YoY despite a 31.7% revenue increase, a negative divergence that persists across the half-year, not just one quarter

Filing sentiment is mixed, with strong revenue offset by weak profitability; no explicit forward guidance was provided to anchor expectations

Revenue run-rate of ~₹9,577 lakh per quarter with 10.7% QoQ growth means even partial recovery in margins from the ₹326 lakh Q2 profit base could produce significant earnings upside

If other expense growth normalises toward revenue growth rates, the gap between 31.1% revenue growth and 20.4% expense growth could rebuild profitability in H2 FY27

Addition of a non-executive non-independent director may signal promoter or strategic investor involvement, potentially supportive of capital allocation discipline

10.7% QoQ revenue growth in Q2 FY27 suggests order book or volume traction that could carry into Q3 FY27

Chembond's 31.1% YoY revenue gain against a 54.7% profit decline illustrates a broader pattern in specialty chemicals where input and overhead inflation absorbs top-line expansion

Combined growth in other expenses (20.4%) and employee costs (11.8%) suggests cost structures are being rebuilt ahead of sustained volume gains, a pattern to test against peers

Collapse in other income (-77% YoY) means reported earnings now rely entirely on operating performance, raising the bar for margin delivery in coming quarters

Shareholder vote on Mrs. Mamta Nirmal Shah's appointment as Non-Executive Non-Independent Director; monitor outcome and any board composition implications

Key test of whether margins recover from Q2's 3.4% net margin level; watch other expense and employee cost trajectory

Management commentary on the 20.4% YoY rise in other expenses, particularly any one-time or structural items

Whether other income remains depressed near ₹9 lakh per quarter, reducing earnings cushion

Whether 10.7% QoQ growth persists into Q3 FY27, which would support a margin recovery thesis

Monitor for any promoter or director trading following the board change and weak Q2 profit print